OXXY, with over 1 lakh medical centres already tied up under its belt, is all set to launch its hospital chain in India. OXXY, valued over USD 2 billion, is all set to launch hospitals in the metros and a few other cities under its belt in next few months. These hospitals will be from 50 bedded to 500 bedded capacity. No other model currently exists in India and its success will purely depend on the affordability of quality treatment and services directly in comparison with the global standards.
United States-based Myriad Genetics, the world's largest molecular diagnostic company, announced a strategic partnership with Positive Bioscience to offer the first of its kind molecular genomic testing in India. Genomic testing is still at an early stage in India and this partnership could revolutionise genomics testing in this country.